CSTM · Constellium SE Ordinary Shares (France)
View on chartInsiders & Stakes
| Joerg Ingrid CEO | ▼ Sell | Tax Withholding | 406,464 Shares held | 7/10/2026 | View profile |
| Piquier Ludovic SVP Manuf Excellence & CTO | ▼ Sell | Open Market | 241,713 Shares held | 5/12/2026 | View profile |
| Guo Jack Q. EVP & CFO | ▼ Sell | Open Market | 185,368 Shares held | 5/5/2026 | View profile |
| Jurkovic Philip Ryan SVP & CHRO | ▼ Sell | Open Market | 172,149 Shares held | 5/1/2026 | View profile |
| Hoffmann Philippe President, A&T | ▼ Sell | Open Market | 144,153 Shares held | 5/1/2026 | View profile |
| Brun Nicolas SVP PA, Comm & Sust | ▼ Sell | Open Market | 104,891 Shares held | 5/11/2026 | View profile |
| Corre Stephane President, AS&I | ▼ Sell | Open Market | 62,313 Shares held | 5/8/2026 | View profile |
| Deslarzes Jean-Christophe Director | ▲ Buy | Open Market | 43,515 Shares held | 8/3/2026 | View profile |
| Brandjes Michiel Director | ▼ Sell | Open Market | 41,600 Shares held | 5/5/2026 | View profile |
| Schild Niklaus SVP CIO & CDO | ▲ Buy | Grant | 38,703 Shares held | 3/12/2026 | View profile |
| Perkins Matthew B. President, P&ARP | ▲ Buy | Grant | 33,212 Shares held | 3/12/2026 | View profile |
| Walters Stephen Charles SVP GC & Secretary | ▲ Buy | Grant | 25,068 Shares held | 3/12/2026 | View profile |
| Ormerod John Director | ▼ Sell | Open Market | 24,873 Shares held | 6/4/2026 | View profile |
| Boccon-Gibod Isabelle Director | ▼ Sell | Open Market | 23,000 Shares held | 2/26/2026 | View profile |
| Becker Marcus SVP CPO | ▼ Sell | Open Market | 16,784 Shares held | 5/28/2026 | View profile |
| Jarrett Martin SVP Chief Innovation Officer | ▼ Sell | Open Market | 15,375 Shares held | 5/14/2026 | View profile |
| Bradley Lee Soultz Chief Executive Officer | ▲ Buy | Open Market | 2,500 Shares held | 5/14/2026 | View profile |
| Weiler Wiebke Director | ▲ Buy | Grant | 625 Shares held | 3/12/2026 | View profile |
Transaction History
| Deslarzes Jean-Christophe | ▲ Buy | Open Market | 1,490 | $41K | 8/3/2026 |
| Joerg Ingrid | ▼ Sell | Tax Withholding | 2,984 | $87K | 7/10/2026 |
| Ormerod John | ▼ Sell | Open Market | 8,000 | $280K | 6/4/2026 |
| Becker Marcus | ▼ Sell | Open Market | 10,391 | $363K | 5/28/2026 |
| Bradley Lee Soultz | ▲ Buy | Open Market | 2,500 | $85K | 5/14/2026 |
| Jarrett Martin | ▼ Sell | Open Market | 4,716 | $158K | 5/14/2026 |
| Piquier Ludovic | ▼ Sell | Open Market | 1,000 | $34K | 5/12/2026 |
| Brun Nicolas | ▼ Sell | Open Market | 26,661 | $902K | 5/11/2026 |
| Corre Stephane | ▼ Sell | Open Market | 5,000 | $168K | 5/8/2026 |
| Brandjes Michiel | ▼ Sell | Open Market | 10,400 | $325K | 5/5/2026 |
| Guo Jack Q. | ▼ Sell | Open Market | 25,201 | $822K | 5/5/2026 |
| Deslarzes Jean-Christophe | ▲ Buy | Open Market | 1,325 | $41K | 5/1/2026 |
| Hoffmann Philippe | ▼ Sell | Open Market | 50,000 | $1.6M | 5/1/2026 |
| Jurkovic Philip Ryan | ▼ Sell | Open Market | 48,784 | $1.6M | 5/1/2026 |
| Corre Stephane | ▼ Sell | Open Market | 5,000 | $160K | 5/1/2026 |
| Becker Marcus | ▼ Sell | Open Market | 10,000 | $251K | 3/16/2026 |
| Weiler Wiebke | ▲ Buy | Grant | 625 | $0 | 3/12/2026 |
| Brun Nicolas | ▲ Buy | Grant | 4,376 | $0 | 3/12/2026 |
| Jurkovic Philip Ryan | ▲ Buy | Grant | 10,210 | $0 | 3/12/2026 |
| Piquier Ludovic | ▲ Buy | Grant | 5,469 | $0 | 3/12/2026 |
| Becker Marcus | ▲ Buy | Grant | 3,938 | $0 | 3/12/2026 |
| Joerg Ingrid | ▲ Buy | Grant | 31,358 | $0 | 3/12/2026 |
| Perkins Matthew B. | ▲ Buy | Grant | 10,210 | $0 | 3/12/2026 |
| Schild Niklaus | ▲ Buy | Grant | 3,355 | $0 | 3/12/2026 |
| Hoffmann Philippe | ▲ Buy | Grant | 12,033 | $0 | 3/12/2026 |
| Corre Stephane | ▲ Buy | Grant | 7,293 | $0 | 3/12/2026 |
| Guo Jack Q. | ▲ Buy | Grant | 19,690 | $0 | 3/12/2026 |
| Walters Stephen Charles | ▲ Buy | Grant | 5,834 | $0 | 3/12/2026 |
| Corre Stephane | ▼ Sell | Open Market | 1,500 | $39K | 3/10/2026 |
| Hoffmann Philippe | ▼ Sell | Open Market | 4,728 | $122K | 3/10/2026 |
| Becker Marcus | ▼ Sell | Open Market | 1,113 | $29K | 3/10/2026 |
| Joerg Ingrid | ▼ Sell | Open Market | 4,614 | $119K | 3/10/2026 |
| Guo Jack Q. | ▼ Sell | Open Market | 41,717 | $1.1M | 3/10/2026 |
| Jurkovic Philip Ryan | ▼ Sell | Open Market | 29,900 | $774K | 3/10/2026 |
| Brun Nicolas | ▼ Sell | Open Market | 17,701 | $437K | 3/9/2026 |
| Brun Nicolas | ▲ Buy | Grant | 23,710 | $0 | 3/9/2026 |
| Corre Stephane | ▲ Buy | Open Market | 8,026 | $0 | 3/9/2026 |
| Hoffmann Philippe | ▲ Buy | Open Market | 71,132 | $0 | 3/9/2026 |
| Becker Marcus | ▲ Buy | Open Market | 14,592 | $0 | 3/9/2026 |
| Joerg Ingrid | ▲ Buy | Grant | 71,132 | $0 | 3/9/2026 |
| Guo Jack Q. | ▲ Buy | Grant | 75,874 | $0 | 3/9/2026 |
| Jurkovic Philip Ryan | ▲ Buy | Grant | 59,276 | $0 | 3/9/2026 |
| Piquier Ludovic | ▲ Buy | Grant | 30,350 | $0 | 3/9/2026 |
| Schild Niklaus | ▲ Buy | Grant | 5,106 | $0 | 3/9/2026 |
| Hoffmann Philippe | ▼ Sell | Open Market | 50,000 | $1.3M | 3/4/2026 |
| Hoffmann Philippe | ▼ Sell | Open Market | 30,000 | $814K | 3/4/2026 |
| Deslarzes Jean-Christophe | ▲ Buy | Open Market | 1,665 | $41K | 3/2/2026 |
| Corre Stephane | ▼ Sell | Open Market | 3,000 | $74K | 2/27/2026 |
| Boccon-Gibod Isabelle | ▼ Sell | Open Market | 10,000 | $258K | 2/26/2026 |
| Corre Stephane | ▼ Sell | Open Market | 3,200 | $82K | 2/25/2026 |
| Walters Stephen Charles | ▼ Sell | Open Market | 1,500 | $38K | 2/23/2026 |
| Becker Marcus | ▼ Sell | Open Market | 15,570 | $398K | 2/20/2026 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Barclays initiates coverage on Constellium with Equal-Weight rating
Barclays has started covering Constellium with an Equal-Weight rating and a $28 price target. This new analyst view comes as the company prepares to report its third-quarter results on October 28, 2026. While some analysts suggest the stock could see further gains, the new target is below the current average analyst estimate of $33.67.
Barclays initiates coverage on Constellium with Equal-Weight rating. Barclays has started covering Constellium with an Equal-Weight rating and a $28 price target. This new analyst view comes as the company prepares to report its third-quarter results on October 28, 2026. While some analysts suggest the stock could see further gains, the new target is below the current average analyst estimate of $33.67.